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ABBREVIATION 
 
 %   -  Percentage 
 µg   -  Micro gram 
 µl   -  Micro litre 
 µm   -  Micro metre 
 ACN   -  Acetonitrile 
 Amt   -  Amount 
 ATC   -  Anatomical Therapeutic Chemical Classification 
 C18   -  Octa Decyl Silane column 
 CAS   -  Chemical Abstracts Service 
 Cm   -  Centimetre 
 CZE   -  Capillary Zone Electrophoresis 
 HPLC   -  High Performance Liquid Chromatography 
 HPTLC  -  High Performance Thin Layer Chromatography 
 Hr    - Hour 
 IUPAC  -  International Union of Pure and Applied Chemistry 
 KH2PO4  -  Potassium Dihydrogen Phosphate 
 LC   -  Liquid Chromatography 
 LC-MS  -  Liquid Chromatography-Mass Spectrophotometry 
 LOD  -  Limit of Detection 
 LOQ   - Limit of Quantitation 
 mg  -  Milli gram 
 min   -  Minute 
 ml   -  Millilitre 
 mm   -  Milli metre 
 nm  -  Nano metre 
 ODS   -  Octa Decyl Silane Column 
 RPLC   -  Reverse Phase Liquid Chromatography 
 RSD  -  Standard Deviation 
 SD  - Standard deviation 
 SEM   -  Standard Error Mean 
 Std   -  Standard 
 Tab   -  Tablet 
 TLC   -  Thin Layer Chromatography 
 UPLC   -  Ultra Performance Liquid Chromatography 
 λmax   -  Absorption maximum 
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1. INTRODUCTION 
 
1.1 A General Approach to Analytical Chemistry 
Analytical Chemistry has been defined in many ways. One of the most widely 
accredited definitions is that of the Working Party on Analytical Chemistry of the 
Federation of European Chemical Societies: “Analytical Chemistry is a scientific 
discipline that develops and applies methods, instruments and strategies to obtain 
information on the composition and nature of matter in space and time.” [1]  
A complementary definition has recently been issued, according to which 
“Analytical Chemistry is a metrological discipline that develops, optimizes and 
applies measurement process intended to derive quality bio-chemical or chemical 
information of global and partial type from natural and artificial objects or systems in 
order to solve analytical problems derived from information need.” 
A trend has recently emerged for the systemic use of metrology in chemistry 
in order to explain the main field of action of analytical chemistry, namely the 
performance of bio-chemical or chemical measurements based on standards with a 
view to establishing comparisons in order to produce qualitative, quantitative and 
structural results. 
1.2 Aims and Objectives of Analytical Chemistry 
The intrinsic aim is the attainment of metrological quality, i.e. ensuring full 
constancy between the analytical results delivered and the actual value of the 
measured parameters; in metrological terms, this translates into producing highly 
traceable results subject to very little uncertainty. 
The extrinsic aim is solving the analytical problems derived from the bio-
chemical or chemical information needs posed by a variety of clients (e.g. private 
companies, social agents and research centers) or in other words providing client 
satisfaction. 
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 The main objective of analytical chemistry is to obtain as much bio-chemical 
or chemical information and of as high a quality as possible from objects and systems 
by using as little material, time and human resources as possible and with minimal 
costs and risks. 1 
 
1.3 Classification of Analytical Chemistry 
Based on the type of bio-chemical or chemical information delivered 
♦ Qualitative Analysis - deals with the identification of elements, ions or 
compounds present in a sample.[2] 
♦ Quantitative Analysis - deals with the determination of how much of one or 
more constituents are present in any compound or mixture of compounds.[3] 
 
Based on the analytical technique used in the analytical process 
♦ Classical Analysis (Wet Analysis) 
 Acid-base titration 
 Non-aqueous titration 
 Argentimetric titration 
 Complexometric titration 
 Redox titration 
 Iodometric titration 
 Diazotization titration [4] 
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♦ Instrumental Analysis  
Spectroscopic Techniques  
 Ultraviolet and visible spectrophotometry 
 Fluorescence spectrophotometry 
 Phosphorescence spectrophotometry 
 Atomic emission spectrometry  
 Atomic absorption spectrometry 
 Infrared spectrophotometry 
 Raman Spectroscopy 
 X-ray spectroscopy 
 Nuclear magnetic resonance spectroscopy 
 Electron spin resonance spectroscopy [5] 
Electrochemical techniques 
 Potentiometric techniques 
 Voltametric techniques 
 Coulometric techniques 
 Amperometric techniques 
 Electrogravimetric techniques 
 Conductance techniques [6] 
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Separation techniques 
 High performance liquid chromatography 
 Gas chromatography 
 High performance thin layer chromatography 
 Paper chromatography 
 Thin layer chromatography 
 Super critical fluid chromatography 
 Capillary Electrophoresis 
 Capillary Electro chromatography 
Hyphenated techniques 
 Gas Chromatography - Mass spectrometry (GC-MS) 
 Gas Chromatography - Fourier Transform Infrared 
Detection (GC-FTIR) 
 Gas Chromatography - Atomic Emission Detection 
(GC-AED) 
 Liquid Chromatography - Mass Spectrometry (LC-MS) 
 Liquid Chromatography - Fourier Transform Infrared 
Detection (LC-FTIR) 
 Liquid Chromatography - Nuclear Magnetic Resonance 
Detection (LC-NMR) 
Miscellaneous techniques 
 Thermal Analysis 
 Radio chemical methods [6] 
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1.4 ULTRAVIOLET AND VISIBLE ABSORPTION 
SPECTROPHOTOMETRY 
 
Ultraviolet and visible absorption spectrophotometry is the measurement of 
the absorption of monochromatic radiation by solutions of chemical substances in the 
range of 185 nm to 380 nm and 380 nm to 780 nm of the spectrum respectively. The 
magnitude of the absorption of a solution is expressed in terms of the absorbance (A) 
defined as the logarithm to base 10 of the reciprocal of transmittance (T) for 
monochromatic radiation: 
 
A = log10 (Io / I) 
 
Where Io is the intensity of the incident radiation and I is the intensity of the 
transmitted radiation. The absorbance depends on the concentration of the absorbing 
substance in the solution and the thickness of the absorbing layer taken for 
measurement. For convenience of reference and for ease in calculations, the specific 
absorbance of a 1 per cent w/v solution is adopted in Pharmacopoeia for several 
substances unless otherwise indicated and it refers to the absorbance of a 1 per cent 
w/v solution in a 1 cm cell and measured at a defined wavelength. It is evaluated by 
the expression 
 
A (1 per cent, 1 cm) = A /cl, 
 
Where c is the concentration of the absorbing substance expressed as 
percentage w/v and l is the thickness of the absorbing layer in cm. The value of A (1 
per cent, 1 cm) at a particular wavelength in a given solvent is a property of the 
absorbing substance. Unless otherwise stated, the absorbance should be measured at 
the prescribed wavelength using a path length of 1 cm and at 24º to 26º. Unless 
otherwise stated, the measurements are carried out with reference to the same solvent 
or the same mixture of solvents. 
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Apparatus 
A spectrophotometer suitable for measuring in the ultraviolet and visible 
ranges of the spectrum consists of an optical system capable of producing 
monochromatic light in the range of 200 nm to 800 nm. The two empty cells used for 
the solutions under examination and the reference liquid must have the same spectral 
characteristics. Where double-beam-recording instruments are used, the solvent cell is 
placed in the reference beam. [7] 
  
Instrument Components 
 
 Figure no. 1 depicts a block diagram of the essential components of a typical 
UV/Vis instrument. Some instruments position the sample/reference compartment 
before the wavelength isolation device. This arrangement permits significantly greater 
intensity of incident light falling on the sample and reference but may result in photo 
degradation of some thermally sensitive samples, possibly creating baseline problems 
with high fluorescent samples. 
 
Figure no. 1 Block diagram of typical instrument for making UV/Vis absorption 
measurements 
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Light source  
 Incandescent tungsten filament lamp 
 Quartz – Iodine lamp 
 Xenon arc lamp 
 Hydrogen or deuterium arc discharge lamp 
Wavelength Isolation Device 
The purpose of the wavelength isolation device is to separate the many 
wavelengths of light coming from the continuum produced by the light source and 
isolate the particular wavelength of interest. 
Spectrophotometer monochromators are using either diffraction grating or 
prisms as dispersive devices. Diffraction gratings are classified as either classically 
ruled or holographic gratings. Prism monochromators are another popular wavelength 
isolation device for spectrophotometers. There are many geometric designs of prisms, 
but the Cornu (60˚- 60˚- 60˚) and the Liittrow (30˚- 60˚- 90˚) prisms are most widely 
used and may be arranged in a variety of configuration. 
 Sample and reference compartments   
Only double-beam instruments have a reference compartment. The double-
beam instrument is usually configured so that monochromatic light from the 
wavelength isolation system is divided in by means of an optical beam splitter and 
passed through both the sample and reference compartments continuously or rapidly 
alternating between the compartments continuously or rapidly alternating between the 
compartments. This allows compensation for small variations in the light source and 
permits continuous blank corrections. The high stability of modern light sources 
coupled with rapid measurement system allows many high-quality instruments to 
incorporate a single-beam optical system without significantly sacrificing 
measurement stability and without the additional expense of the double-beam optics 
system. [8] 
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Detectors 
For the accurate determination of substances by spectrophotometric 
techniques, precise determinations of the light intensities are necessary. Photoelectric 
detectors are most frequently used for this purpose. They must be employed in such a 
way that they give response linearity proportional to the light input and they must 
suffer from drift or fatigue. 
 Barrier-layer cells 
 Phototubes 
 Photomultiplier tubes 
 Photo diodes 
 Thermocouples 
 Bolometer 
 Thermistors 
 Golay detector [9] 
Data Output and Data-Processing Device 
Signal output devices can be as simple as an analog absorbance or 
transmittance meter where the data are read, recorded and processed by the operator. 
Some systems use logic circuitry to provide digital readouts in transmittance, 
absorbance or concentration. Most modern spectrophotometers now incorporate 
microprocessors for control and monitoring of instrument operation. These systems 
commonly provide an interface to a computer system along with software to control 
instrument operations, data collection and data processing.[8] 
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1.5 LIQUID CHROMATOGRAPHY 
Liquid chromatography (LC) is a method of chromatographic separation based 
on the difference in the distribution of species between two non-miscible phases, in 
which the mobile phase is a liquid which percolates through a stationary phase 
contained in a column.1  
Liquid chromatography is mainly based on mechanisms of adsorption in 
liquid-solid chromatography, mass distribution in normal phase liquid 
chromatography (NPLC) and reversed-phase chromatography (RPLC), ionic in ion-
exchange chromatography (IEC), size exclusion or stereo chemical interaction in size-
exclusion chromatography (SEC) and affinity in affinity chromatography. [10]  
Table no: 1 Classification of liquid chromatographic techniques 
Technique Main separation 
mechanism 
Stationary phase Mobile phase 
Adsorption 
chromatography 
Adsorption Polar material 
such as silica or 
alumina 
Non-polar 
solvents 
NPLC Distribution/adsorption Polar material Non-polar 
solvents 
RPLC Distribution Non-polar material Polar solvents 
IEC Ion-Exchange Charged solid 
phase material 
Typical 
aqueous buffer 
solutions 
SEC Size exclusion Porous solid phase 
material 
Organic or 
aqueous 
solvents 
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Instrumentation 
 The modules of HPLC unit are illustrated in figure no. 2. It consists of a pump 
unit, solvent reservoirs, an injector, a column and a detector. The principle of 
operation is simple. The pump pushes the eluent through the column at a certain flow 
rate. When injecting the sample, the eluent passes through the injector and transfers 
the sample in to the column. In the column, the sample components are separated 
components are detected at the detector. In modern LC instruments the operations are 
controlled by a computer. In most instruments it is possible to control the temperature 
of the eluent and column. In order to minimize peak broadening, the dead volume of 
the unit, especially in the injection system and in the detector must be kept small. 
Figure no. 2 Structure of a HPLC unit with precolumn 
 
 
Solvents 
 The selection of the eluent is dependent on the technique used. Generally, the 
solvent used in HPLC should be filtered before use, to remove suspended particles 
that could easily block the LC system. Dissolved gases should also be removed, either 
by out gassing with helium or nitrogen or by processing in an ultrasonic bath. The 
solvents used as the mobile phase are stores in a reservoir in glass or stainless steel 
bottles. 
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 In HPLC, the separation can be achieved by either isocratic or gradient 
elution. In the isocratic method, the solvent composition is constant during the 
separation. Better separation in shorter analysis time is usually obtained by using 
gradient elution, in which the eluent composition is gradually changed during the 
analysis. Two or more eluents can be used in gradient elution and the gradient can be 
linear, stepwise, concave or convex. Typically, the elution strength of the solvent is 
increased in the gradient method. Thus, in RPLC the amount of organic solvent (e.g. 
acetonitrile) is increased while the amount of aqueous buffer is decreased. 
Pumping systems 
 The requirements for a HPLC pump are high: The pump should be able to 
produce pressures up to 400 bar (40MPa) with a large range of flow rates (0.05 - 10 
ml min-1) and the flow should be free of pulsation. Also, the inner volume of the 
pump should be small enough to enable a quick change of the eluent composition. In 
addition, reproducibility and control of the flow with a relative error of less than 0.5% 
should be obtained. The most common pumps in HPLC systems are displacement and 
reciprocating pumps. 
 Stainless steel, Teflon or ceramics are used as materials. The high-pressure 
strain is obtained using sapphire valves. One differentiates between reciprocating and 
displacement pumps. Displacement pumps works like a syringe. A specific volume 
approximately 200 ml of the mobile phase is sucked in and then discharged free of 
pulsation in to the HPLC system. A crucial disadvantage however is the interruption 
of the delivery process in order to fill or rinse the piston. Displacement pumps are still 
used in micro-HPLC, since the composition of mobile phase during one analysis is 
small. 
 Reciprocating pumps are preponderant today. As a rule, they are operated as 
double-piston pumps, which work with a phase shift of 180˚ to suppress pulsation. 
They are also called oscillating (inverse) displacement pumps. To avoid direct contact 
with solvent with the pump valves, the pumps are also available as piston diaphragm 
pumps. Here, the piston movement is transferred to a diaphragm using hydraulics. The 
operation of the pumps is based on the movement of the piston, when the piston 
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moves backwards, it sucks eluent from the reservoir and on the forward movement 
and it pushes the eluent in to the column. 
The advantage of the short piston pump are the small internal volumes of 40 to 
400 μl, the high pressure outlet of up to 60 MPa, as well as the constant flow, which is 
independent of the back pressure of the column and the solvent viscosity. 
  Gradients can be produced on the low-pressure or high-pressure side. If one 
mixes the two or three compartment solvents of an eluent mixture on the suction side 
of a pump, one refers to a low-pressure gradient. 
 Two pumps are required to produce a high-pressure gradient. A single solvent 
constituent or in the case of ternary mixtures, two constituents are presented in a 
constant relationship. The third constituent is admixed-in on the pressure side of the 
pump after the gradient program. 
 High-pressure gradients are more precisely composed than low-pressure 
gradients. This can be ascribed to the fact that the volume contraction when the 
various solvents are mixed can become significant in the low-pressure variant. 
 To avoid damaging the pump and contaminating the column particles, the 
sample solution should be filtered prior to injection e.g. by passing it through a 1 μm 
filter. 
Injection System 
The sample injection system must allow volumes in the range from 1 to 500 μl 
to be introduced. In micro-HPLC, the sample volumes are much lower (< 1 μl) and a 
different injection system is required than in conventional size HPLC. During the 
injection, the pressure should be kept constant in the system. The most commonly 
used injection system is presented in fig no. 3. It consists of a six-way valve, to which 
a sample loop has been attached. The sample is injected into the loop by means of 
micro liter syringe. While the loop is being filled, the eluent flows directly to the 
column. By switching the valve, the eluent flow is directed via the sample loop to the 
column. After injection, the valve is switched to its original position. The size of the 
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loop can be varied. In micro-HPLC systems, the sample loop is replaced with a 
groove in the valve, because it is difficult to produce sufficiently small loops. 
  
Figure no. 3 Injection valve of HPLC 
 
 
 
 
 Automated sample injection systems are preferred for high-precision sample 
introduction. These are also based on sample loops and are operated by compressed-
air switching. 1 
Columns 
 For most pharmaceutical analyses, separation is achieved by partition of 
compounds in the test solution between the mobile and stationary phases. A system 
consisting of polar stationary phases and non-polar mobile phases are described as 
normal phase, while the opposite arrangement, polar mobile phases and nonpolar 
stationary phases and is called reverse-phase chromatography. Partition 
chromatography is almost always used for hydrocarbon-soluble compounds of 
molecular weight less than 1000. The affinity of a compound for the stationary phase 
and thus its retention time on the column is controlled by making the mobile phase 
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more or less polar. Mobile phase polarity can be varied by the addition of a second 
and sometimes a third or even a fourth component. 
 Stationary phases for modern reverse-phase liquid chromatography typically 
consist of an organic phase chemically bound to silica or other materials. Particles are 
usually 3 to 10 μm in diameter, but sizes may range up to 50 μm or more for 
preparative columns. Small particles thinly coated with organic phase provide for low 
mass transfer resistance and hence rapid transfer of compounds between the stationary 
and mobile phases. Column polarity depends on the polarity of the bound functional 
groups, which range from relatively non-polar octadecyl silane to very polar nitrile 
groups. Liquid non-bound stationary phases must be largely immiscible in the mobile 
phase. Even so it is usually necessary to presaturate the mobile phase with stationary 
phase to prevent stripping of the stationary phase from the column. Polymeric 
stationary phases coated on the support are more durable. 
 Columns used for analytical separations usually have internal diameters of 2 
to 5 mm; larger diameter columns are used for preparative chromatography. Columns 
may be heated to give more efficient separations, but only rarely are they used at 
temperatures above 60˚ because of potential stationary phase degradation or mobile 
phase volatility. Unless otherwise specified in the individual monograph, columns are 
used at ambient temperature. 
 In Size-exclusion chromatography the column is packed with a separation 
material that is capable of fractionation in the appropriate range of molecular sizes 
and through which the eluent is passed at a constant rate. One end of the column is 
usually fitted with a suitable device for applying the sample, such as a flow adaptor, a 
syringe through a septum or an injection valve and it may also be connected to a 
suitable pump for controlling the flow of the eluent. Alternatively, the sample may be 
applied directly to the drained bed surface or where the sample is denser than the 
eluent, it may be layered beneath the eluent. The packing material may be a soft 
support such as a swollen gel or a rigid support composed of a material such as glass, 
silica or a solvent-compatible, cross-linked organic polymer. Rigid supports usually 
require pressurized systems giving faster separations. The mobile phase is chosen 
according to sample type, separation medium and method of detection. 
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 Ion-exchange chromatography is used to separate water-soluble, ionizable 
compounds of molecular weight less than 1500. The stationary phases are usually 
synthetic organic resins; cation-exchange resins contain negatively charged active 
sites and are used to separate basic substances such as amines, while anion-exchange 
resins have positively charged active sites for separation of compounds with 
negatively charged groups, such as phosphate, sulfonate or carboxylate groups. 
Water-soluble ionic or ionizable compounds are attracted to the resins and differences 
in affinity bring about the chromatographic separation. The pH of the mobile phase, 
temperature, ion type, ionic concentration and organic modifiers affect the 
equilibrium and these variables can be adjusted to obtain the desired degree of 
separation.[1] 
Detectors 
 Ultraviolet/visible (UV/Vis) spectrophotometers, including diode array 
detectors are the most commonly employed detectors. Fluorescence 
spectrophotometers, differential refractometers, electrochemical detectors, mass 
spectrometers, light scattering detectors, radioactivity detectors or other special 
detectors may also be used. [10]     
 
♦ Absorbance detectors 
  Many compendial HPLC methods require the use of 
spectrophotometric detectors. Such a detector consists of a flow-through cell 
mounted at the end of the column. A beam of UV radiation passes through the 
flow cell and into the detector. As compounds elute from the column, they 
pass through the cell and absorb the radiation, resulting in measurable energy 
level changes.  
  Fixed, variable and multi-wavelength detectors are widely available.  
Fixed wavelength detectors - It is operate at a single wavelength typically 254 
nm emitted by a low-pressure mercury lamp. 
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 Variable wavelength detectors - It contains a continuous source, such as a 
deuterium or high-pressure xenon lamp and a monochromator or an 
interference filter to generate monochromatic radiation at a wavelength 
selected by the operator. The wavelength accuracy of a variable-wavelength 
detector equipped with a monochromator should be checked by the procedure 
recommended by its manufacturer; if the observed wavelengths differ by more 
than 3 nm from the correct values; recalibration of the instrument is indicated.  
Modern variable wavelength detectors - This can be programmed to change 
wavelength while an analysis is in progress.  
Multi-wavelength detectors - This measure the absorbance at two or more 
wavelengths simultaneously.  
 Diode array multi-wavelength detectors - In this continuous radiation is 
passed through the sample cell and then resolved into its constituent 
wavelengths, which are individually detected by the photodiode array. These 
detectors acquire absorbance data over the entire UV-visible range, thus 
providing the analyst with chromatograms at multiple, selectable wavelengths 
and spectra of the eluting peaks. Diode array detectors usually have lower 
signal-to-noise ratios than fixed or variable wavelength detectors and thus are 
less suitable for analysis of compounds present at low concentrations. 
♦ RI detector (refractometers) 
  Differential refractrometer detectors measure the difference between 
the refractive index of the mobile phase alone and that of the mobile phase 
containing chromatographed compounds as it emerges from the column. 
Refractive index detectors are used to detect non-UV absorbing compounds, 
but they are less sensitive than UV detectors. They are sensitive to small 
changes in solvent composition, flow rate and temperature, so that a reference 
column may be required to obtain a satisfactory baseline. [11] 
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♦ Fluorescence detectors 
  Compared with UV detectors, up to about 1000-fold higher sensitivity 
can be achieved using fluorescence detectors. In fluorescence detectors the 
excitation source is most frequently a mercury vapor lamp. Xenon high-
pressure lamps are also employed for more demanding tasks. In addition, the 
excitation and emission wavelengths can be selected by monochromators or a 
fluorescence spectrometer can be used as a detector. The intrinsic fluorescence 
of substances can often be exploited in analysis of drugs, of clinically relevant 
compounds or of natural substances. To detect non-fluorescent compounds the 
substances to be determined first have to be derivatized. [1] 
♦ Electrochemical detectors 
  Voltammetry, amperometry, coulometry and conductimetry can be 
exploited for electrochemical detection. 
  These detectors are selective, sensitive and reliable, but require 
conducting mobile phases free of dissolved oxygen and reducible metal ions.  
Pulseless pump must be used and care must be taken to ensure that the pH, 
ionic strength and temperature of the mobile phase remain constant. Working 
electrodes are prone to contamination by reaction products with consequent 
variable responses. 
  Electrochemical detectors with carbon-paste electrodes may be used 
advantageously to measure nanogram quantities of easily oxidized 
compounds, notably phenols and catechols. [11] 
♦ Evaporative light scattering detector (ELSD) 
  Detection is based on the scattering of a beam of light by particles of 
compound remaining after evaporation of the mobile phase. This detector is of 
growing importance; it is a universal and does not require a compound to have 
a chromophore for detection. Application includes the analysis of surfactants, 
lipids and sugars. Unlike the refractive index detector, which was formerly 
used for this analysis, it can be used with gradient elution and is robust enough 
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to function under a wide range of operating conditions. However, it cannot be 
used with in-volatile materials such as buffers in the mobile phase or to detect 
very volatile analytes. Typical applications include: analysis of chloride and 
sodium ions in pharmaceuticals, lipids used as components in formulations, 
sugars and sugar polymers. [4] 
♦ Mass spectrometer 
  The mass spectrometer is a very important HPLC detector because of 
its ability to generate structural and molecular weight information about the 
eluted solutes. The combination of HPLC and mass spectrometry allows for 
both separation and identification in the same step, an advantage none of the 
other detectors provide. 
  The major difficulty in using mass spectrometry is in designing the 
interface. The flow rate in HPLC is on the order of 1 ml/min, which are two or 
three orders of magnitude larger than the flow that can be taken by the 
conventional mass spectrometer vacuum systems. A second problem with 
using mass spectrometry is the difficulty of vaporizing non-volatile and 
thermally labile molecules without degrading them. [8] 
 
Data Collection Devices 
 Modern data stations receive and store detector output and print out 
chromatograms complete with peak heights, peak areas, sample identification and 
method variables. They are also used to program the liquid chromatograph, 
controlling most variables and providing for long periods of unattended operation.  
 Data also may be collected on simple recorders for manual measurement or 
on stand-alone integrators, which range in complexity from those providing a printout 
of peak areas to those providing chromatograms with peak areas and peak heights 
calculated and data stored for possible subsequent reprocessing. [11] 
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2. DRUG PROFILE  
2.1 NOMENCLATURE  
Structure  
 
CAS Registry number   
91374-20-8  
ATC Code   
N04BC04 
IUPAC Name  
  4-[2-(dipropylamino) ethyl]-1, 3-dihydro-2H-indol-2-one 
 Molecular Formula  
  C6H24N2O. HCl 
 Molecular Weight  
  296.84 g/mol [12] 
 Percent Composition of Atoms 
  C – 64.74 %, H – 8.49 %, N – 9.44 %, O – 5.39 %, Cl – 11 % [13] 
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2.2 PHYSICAL AND CHEMICAL PROPERTIES 
 Description 
  White to pale greenish yellow crystalline powder 
 Distribution coefficient (Octanol/ Water) 
  Log P = 3.32 in Phosphate buffer at pH 7.4 
 Dissociation Constant (pKa) 
  9.5 for tertiary amine  
  11.6 for indole nitrogen 
 Solubility 
  Soluble in water and in dilute Hydrochloric acid  
  Slightly soluble in ethyl alcohol  
  Insoluble in methylene chloride 
 Melting Point 
  241 to 243 ˚C 
 Storage  
  Store at 20 to 25 ˚C, Protected from light. 
 
2.3 PHARMACEUTICAL FORMS: 
 In India Ropinirole Hydrochloride is available in the range of 0.25 mg, 0.5 
 mg, 1 mg and 2mg as film coated tablets and 4mg as extended release tablets. 
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2.4 PHARMACOLOGY  
Indication 
 It is used in the management of Parkinson's disease, either alone or as 
an adjunct to levodopa. 
 It is used in the treatment of Restless Leg Syndrome (RLS). [14] 
Mechanism of Action 
Ropinirole is a non-ergoline dopamine agonist with high relative in 
vitro specificity and full intrinsic activity at the D2 and D3 dopamine receptor 
subtypes, binding with higher affinity to D3 than to D3 or D4 receptor 
subtypes. 
Dosage 
 As monotherapy in Parkinson's disease: 
Adult: Initially, 250 μg tid may increase by 750 μg at weekly intervals 
for the first 4 week. Subsequent increments can be made in steps of 1.5 
mg at weekly intervals up to 9 mg/day, then in steps of 3 mg at weekly 
intervals. Usual dose ranges from 3-9 mg daily. Max: 24 mg/day. 
Higher dose may be necessary if used in conjunction with levodopa.  
 Restless leg syndrome: 
Adult: Initially, 250 μg daily for 2 days, taken 1-3 hr before bedtime. 
May increase to 500 μg daily for the next few days, subsequent 
increments may be made in steps of 500 μg at weekly intervals until 3 
mg daily is reached. Maximum dose: 4 mg daily. [15] 
Contraindication 
Contraindicated for patients known to have hypersensitivity reaction 
(including urticaria, angioedema, rash, pruritus) [16] 
 
 Chapter 2                                                                                                                              Drug Profile 
 
Dept. of pharmaceutical analysis  22 
 
Adverse Drug Reactions  
Nausea, vomiting, somnolence, insomnia, dyspepsia, dizziness, hallucinations, 
tremors, abdominal pain, depression, headache, edema of the legs, ataxia, anxiety and 
symptomatic hypotension [17] [18] 
 
Drug - Drug Interactions 
Ciprofloxacin  : Inhibition of ropinirole metabolism    
Antipsychotics  : Antagonise the effect of ropinirole 
Memantine  : Enhancing the effect of ropinirole 
Methyldopa  : Antagonise the effect of ropinirole 
Metoclopramide : Antagonise the effect of ropinirole 
Oestrogens  : Increase in the plasma concentration of ropinirole [12]  
 
Pharmacokinetics 
 Absorption     : Rapidly absorbed from the GI tract  
Bioavailability   : About 50% 
Distribution   : Widely distributed 
Plasma protein binding  : 10-40% 
Metabolism   : Extensively metabolized in the liver by CYP1A2 
Excretion   : Excreted in the urine as inactive metabolites;  
     less than 10% of the oral dose is excreted unchanged 
Elimination half-life   : About 6 hours [19] [20] [21] 
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3. LITERATURE REVIEW 
 
3.1 Spectroscopic Methods 
 
♦ M.V.Kumudhavalli et al. [22] [2011] have developed and reported a validated 
spectrophotometric method for the determination of Ropinirole in pharmaceutical 
formulation. Distilled water was used as a solvent throughout the study. 
Quantitative determination of Ropinirole in pharmaceutical formulation was 
carried out by UV spectrophotometric method using λ max at 249.0 nm. The 
method showed high specificity in the presence of formulation excipients and 
good linearity in the concentration range of 10-30 µg/ml. Percentage recovery 
values at 249.0 nm were 96 to 101.30% .The intra and interday precision data 
demonstrated that method was precised. The method was validated in terms of 
accuracy, precision and specificity. The method could be routinely adopted for 
quality control of these drugs in tablet. 
 
♦ Sudarshan Purohit et al. [23] [2010] have reported a simple, sensitive and 
selective UV spectroscopy method for the estimation of ropinirole HCl in 
pharmaceutical formulation. Estimation of drug was performed in 0.1 N HCl at 
230 nm. The validation studies were carried out with reference to ICH 
requirements. The developed method was found to be specific, linear, precise 
(including both intra- and inter-day), accurate and robust. This proposed method 
might represent a valuable aid in the routine quality estimation of ropinirole HCl. 
 
♦ Vishnu P. Choudhari et al. [24] [2010] have described two simple, precise and 
economical UV spectrophotometric methods for the estimation of ropinirole in 
pharmaceutical dosage form. In Method (A) area under curve (AUC) tool was 
applied and in which area under curve was integrated in the wavelength range of 
234.36 – 241 nm. Method (B) involved first order derivative spectrum of drug 
solution and measurement of derivative amplitude at 262.58 nm. Calibration 
curves were plotted for both methods by using instrumental response at selected 
wavelength and concentrations of analyte in the solution. Linearity for the detector 
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response was observed in the concentration range of 4-20 μg/ml for both the 
methods. Two tablet formulations were analyzed and percentage assay determined 
was 99.79% – 100.68%. Accuracy and precision studies were carried out and 
results were satisfactory. The proposed methods were validated as per ICH 
analytical method development guidelines. The results of the analysis were 
validated statistically. Limit of detection and limit of quantitation were determined 
for both methods. 
 
♦ Shete Yogita et al. [25] [2009] have developed and reported a simple, sensitive, 
rapid, accurate and precise spectrophotometric method for estimation of ropinirole 
hydrochloride in bulk and tablet dosage forms. Ropinirole hydrochloride showed 
maximum absorbance at 250 nm with molar absorptivity of 8.703×10 3 l/mol.cm. 
Beer's law was obeyed in the concentration range of 5-35 µg/ml. Results of 
analysis were validated statistically and by recovery studies. 
 
♦ Aydogmus Zeynep [26] [2008] has reported three sensitive, selective, accurate 
spectrophotometric and spectrofluorimetric methods for the determination of 
ropinirole hydrochloride in tablets. The first method was based on measuring the 
absorbance of drug solution in methanol at 250 nm. The Beer's law was obeyed in 
the concentration range 2.5–24 μg ml−1. The second method was based on the 
charge transfer reaction of drug, as n-electron donor with 7,7,8,8-
tetracyanoquinodimethane (TCNQ), as π-acceptor in acetonitrile to give radical 
anions that were measured at 842 nm. The Beer's law was obeyed in the 
concentration range 0.6–8 μg ml−1. The third method was based on derivatization 
reaction with 4-chloro-7-nitrobenzofurazan (NBD-Cl) in borate buffer of pH 8.5 
followed by measuring the fluorescence intensity at 525 nm with excitation at 464 
nm in chloroform. Calibration curve was constructed in the concentration range 
0.01-1.3 μg ml−1. The derivatization reaction product of drug with NBD-Cl was 
characterized by IR, 1H NMR and mass spectroscopy. The developed methods 
were validated by parameters such as the molar absorptivity, limit of detection 
(LOD, μg ml−1) and limit of quantitation (LOQ, μg ml−1), precision, accuracy, 
recovery, and Sandell's sensitivity. Selectivity was validated by subjecting stock 
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solution of ropinirole to acidic, basic, oxidative and thermal degradation. No 
interference was observed from common excipients present in formulations. The 
proposed methods were successfully applied for determination of drug in tablets. 
The results of these proposed methods were compared with each other 
statistically. 
 
♦ Armagan Onal et al. [27] [2007] have developed simple and reproducible 
spectrophotometric methods for the determination of dopaminergic drugs used for 
Parkinson's disease, cabergoline (CAB) and ropinirole hydrochloride (ROP), in 
pharmaceutical preparations. The methods were based on the reactions between 
the studied drug substances and ion-pair agents [methyl orange (MO), 
bromocresol green (BCG) and bromophenol blue (BPB)] and yellow colored ion-
pair complexes were produced in acidic buffers; Then the ion-pair complexes 
were extracted in dichloromethane and which were spectrophotometrically 
determined at the appropriate wavelength of ion-pair complexes. Beer's law was 
obeyed within the concentration range from 1.0 to 35 μg ml−1. The developed 
methods were applied successfully for the determination of these drugs in tablets. 
 
♦ J. V. Susheel et al. [28] [2007] have described a Ultra Violet Spectroscopy for the 
determination of ropinirole hydrochloride in tablet dosage forms. Detection 
wavelength was found to be 250 nm using ethanol as a solvent. For this method 
the linearity was found to be in the range of 5-30 μg/ml. The developed method 
could be applied for routine analysis of ropinirole hydrochloride from tablet 
dosage forms. 
 
♦ Mahaki Hanieh et al. [29] [2011] have reported the interaction between ropinirole 
hydrochloride and Human serum albumin as binary system by Three-dimensional 
Fluorescence Spectroscopy. The emission wavelength was recorded between 300 
and 600 nm, the initial excitation wavelength was set to 200 nm with increment of 
10 nm. Peak (a) was the Rayleigh scattering peak (=) and peak (b) was the second-
ordered scattering peak (= 2). The fluorescence intensity of peak (a) and peak (b) 
was increased with the addition of Ropinirole hydrochloride. The possible reason 
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was that a RP–HSA complex was formed after the addition of ropinirole 
hydrochloride followed by increasing the diameter of the macromolecule which in 
turn resulted in an enhanced scattering effect. Peak 1 mainly revealed the spectral 
behavior of Tryptophan and Tyrosine residues. The reason was that when HSA 
was excited at 280 nm, it mainly revealed the intrinsic fluorescence of Tryptophan 
and Tyrosine residues. Beside peak 1, there was another fluorescence peak 2 (= 
230.0 nm, = 340.0 nm) that mainly reflected the fluorescence spectral behavior of 
the polypeptide backbone structure of HSA. The fluorescence intensity of peak 2 
decreased after the addition of ropinirole hydrochloride, which showed that the 
peptide strands structure of HSA had been changed. 
 
♦ Hanieh Mahaki [30] [2011] has reported a binding analysis of Ropinirole 
Hydrochloride and Aspirin to Human Serum Albumin by Synchronous 
Fluorescence. Fluorescence measurements were carried out on a F-2500 (Hitachi, 
Japan) with a 150W Xenon lamp spectrofluorimeter. Synchronous fluorescence 
gave information about the molecular environment in a vicinity of the 
chromophore molecule. The D-value (Δλ) between excitation and emission 
wavelengths was stabilized at 15 or 60 nm; the synchronous fluorescence gave the 
characteristic information of tyrosine or tryptophan residues. Fluorescence 
intensity decreased regularly with the addition of Ropinirole Hydrochloride and 
Aspirin. The synchronous fluorescence spectra of Human Serum Albumin with 
various amounts of Ropinirole Hydrochloride and Aspirin were recorded at Δλ=60 
nm. The tryptophan fluorescence emission of Aspirin was decreased regularly, but 
no significant change in wavelength was observed. At the same time, the emission 
wavelength of the tryptophan residues was slight blue-shifted in Ropinirole 
hydrochloride.  
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3.2 Chromatographic Techniques 
 
♦ Sundaramurthy Poongothai et al. [31] [2011] have developed a dissolution 
test for in vitro evaluation of tablet dosage forms containing 5 mg of ropinirole 
by reverse phase high performance liquid chromatography. A discriminatory 
dissolution method was established using apparatus basket at a stirring rate of 
50 rpm with 500 ml of pH 4.0 deaerated citrate buffer as dissolution medium 
and detection was carried out at 250 nm. The retention time of ropinirole 
hydrochloride was found to be 3.84 minutes. The proposed method was 
validated to meet requirements for a global regulatory filing which included 
linearity, specificity, precision, accuracy, ruggedness and robustness and to 
evaluate the formulation during an accelerated stability study. The method 
could be applied for the quality-control analysis of ropinirole tablets. 
Moreover, quantitative analysis was also performed, to compare the 
applicability of the RP-LC and the LC-MS/MS methods. 
 
♦ Ch. Krishnaiah et al. [32] [2010] have reported a novel stability-indicating 
gradient reverse phase ultra performance liquid chromatographic (RPUPLC) 
method for the determination of purity of ropinirole in presence of its 
impurities and forced degradation products. The method was developed using 
Waters Aquity BEH 100 mm, 2.1 mm, 1.7 μm C-8 column with mobile phase 
containing a gradient mixture of solvent A and B. The eluted compounds were 
monitored at 250 nm. The run time was within 4.5 min in which ropinirole and 
its four impurities were well separated. Ropinirole was subjected to the stress 
conditions of oxidative, acid, base, hydrolytic, thermal and photolytic 
degradation. Ropinirole was found to degrade significantly in oxidative and 
base stress conditions and stable in acid, water, hydrolytic and photolytic 
degradation conditions. The degradation products were well resolved from 
main peak and its impurities. Thus it proved the stability indicating power of 
the method. The developed method was validated as per International 
Conference on Harmonization (ICH) guidelines with respect to specificity, 
linearity, limit of detection, limit of quantification, accuracy, precision and 
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robustness. This method was also suitable for the assay determination of 
ropinirole in pharmaceutical dosage forms and dissolution studies. 
 
♦ N.Sreekanth et al. [33] [2009] have described a simple and accurate RP-HPLC 
method has been developed for the estimation of ropinirole hydrochloride in 
bulk and pharmaceutical dosage forms using C18 column 250 x 4.6 mm i.d, 
5μm particle size in isocratic mode, with mobile phase comprising of buffer 
(pH 6.0) and Acetonitrile in the ratio of 50:50 v/v. The flow rate was 
0.5ml/min and detection was carried out by UV detector at 245nm. The 
retention time for Ropinirole Hydrochloride was found to be 4.867 min. The 
proposed method has permitted the quantification of ropinirole hydrochloride 
over linearity in the range of 5-50µg/ml and its percentage recovery was found 
to be 99.3-100.4%. The intraday and inter day precision were found 0.27% 
and 0.26% respectively. 
 
♦ Saral et al. [34] [2009] have reported a validated RP-HPLC method for the 
estimation of Ropinirole hydrochloride in tablet dosage form and its IVIVC 
studies. The chromatographic conditions were, 
Column : Octadecyl carbon chain bonded silica column 
Mobile Phase  : Phosphate buffer (pH 6.5): Acetonitrile (70:30) 
Flow rate  : 1 ml min -1 
Detection  : UV detection at 250 nm 
 
Linearity was found to be over a range of 25 to 150 % of actual concentration 
(r = 0.9999), with limit of detection and quantification of 0.062 and 0.186 µg 
ml-1, respectively. The analytical method passed both robustness and 
ruggedness tests. In both cases, relative standard deviation was well 
satisfactory. The method could be used for quality control assay of ropinirole 
hydrochloride. The results obtained from the dissolution in different media 
showed that the release was almost similar in all the media but pH 4.0 citrate 
buffer was considered to be the discriminating media considering that the 
medium showed variation as a result of change in formulation of the drug. The 
Chapter 3                                                                                                                       Literature review 
 
Dept. of pharmaceutical analysis  29 
 
drug was freely and rapidly soluble in water, so the sink condition was not 
mandatory. The volume of dissolution media was selected as 500ml based on 
poor absorbance as that of 900ml. After optimizing, the complete method 
validation was made with various parameters. The dissolution data i.e. 
percentage drug released at 15 minutes which have a close linear relationship 
with correlation coefficient as 0.9968 and slope around unity with the 
biological property i.e. Cmax. 
♦ B. Jancic-Stojanovic et al. [35] [2009] have reported a chemometrical 
evaluation of ropinirole and its impurity's (4-[2-(dipropylamino) ethyl]-1H-
indol-2, 3-Dione) chromatographic behavior in systematic and the most 
efficient way. Face-centered central composite design (CCD) with 23 full 
factorial designs, ±1 star design and four replication in central point was 
applied for a response surface study, in order to examine in depth the effects 
of the most important factors. Factors—independent variables (acetonitrile 
content, pH of the mobile phase and concentration of sodium heptane 
sulfonate in water phase) were extracted from the preliminary study and as 
dependent variables five responses (retention factor of ropinirole, retention 
factor of its impurity, resolution, symmetry of ropinirole peak and symmetry 
of impurity peak) were selected. For the improvement of method development 
and optimization step, Derringer's desirability function was applied 
simultaneously to optimize the five chosen responses. The procedure allowed 
deduction of optimal conditions and the predicted optimum was acetonitrile-5 
mM of sodium heptane sulfonate (21.6:78.4, v/v), pH of the mobile phase 
adjusted at 2.0 with ortho phosphoric acid. By calculating global desirability's 
determination coefficients (), as well as by the visual inspection of 3D graphs 
for global desirability, robustness of the proposed method was also estimated. 
♦ A. Azeem et al. [36] [2008] have disentangled an accurate, sensitive, precise, 
rapid, and isocratic reversed phase High performance liquid chromatography 
(RP-HPLC) method for analysis of ropinirole in the bulk drug and in 
pharmaceutical preparations. The best separation was achieved on a 250 mm × 
4.6 mm i.d, 5-μm particle, C18 reversed-phase column with   methanol: 0.05 M 
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ammonium acetate buffer (pH 7) 80:20 (v/v) as mobile phase, at a flow rate of 
1 ml min-1. UV detection was performed at 250 nm. The method was linear 
over the concentration range 0.2–100 μg ml-1 (r = 0.9998), with limits of 
detection and quantitation of 0.061 and 0.184 μg ml-1, respectively. The drug 
was subjected to oxidation, hydrolysis, photolysis, and heat as stress 
conditions. Degradation products resulted from the stress did not interfere with 
detection and assay of ropinirole and thus the method could be regarded as 
stability-indicating. The method could be used for quality-control assay of 
ropinirole. 
 
♦ B. Sahasrabuddhey et al. [37] [2007] have isolated three impurities in 
ropinirole hydrochloride drug substance at levels 0.06–0.15% were detected 
by using reverse-phase high performance liquid chromatography (HPLC). 
These impurities were analyzed using reverse-phase HPLC. Based on the 
spectral data (IR, NMR and MS), structures of these impurities were 
characterized as 4-[2-(propylamino) ethyl]-1,3-dihydro-2H-indol-2-one 
hydrochloride (impurity-A), 5-[2-(dipropylamino) ethyl]-1,4-dihydro-3H-
benzoxazin-3-one hydrochloride (impurity-B) and 4-[2-(dipropylamino) 
ethyl]-1H-indol-2,3-dione hydrochloride (impurity-C). Synthesis of these 
impurities was discussed. 
The present study was illustrated the isolation of three process related 
unknown impurities of ropinirole hydrochloride by preparative HPLC which 
were further characterized using various spectroscopic techniques. 
 
♦ Armagan Onal [38] [2006] have explicated a reversed-phase high-performance 
liquid chromatographic (HPLC) method with UV detection for the 
determination of ropinirole (ROP) in tablets. The assay utilized UV detection 
at 250 nm and a Luna CN column (250 × 4.6 mm I.D, 5 μm). The mobile 
phases were comprised of acetonitrile: 10 mM nitric acid (pH 3.0) (75:25, 
v/v). Validation experiments were performed to demonstrate linearity, 
accuracy, precision, limit of quantitation (LOQ), limit of detection (LOD), and 
robustness. The method was linear over the concentration range of 0.5–10.0 
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μg mL−1. The method showed good recoveries (99.75–100.20%) and the 
relative standard deviations of intra and inter-day assays were 0.38–1.69 and 
0.45–1.95%, respectively. The method could be used for quality control assay 
of ropinirole. 
♦ Jeffery Hackett [39] [2006] has evaluated solid-phase sorbents for the analysis 
of ropinirole in whole blood. In this method, drug free blood was spiked with 
ropinirole (0 to 10 ng) and an internal standard (quinidine). The samples were 
buffered with distilled water and centrifuged. The supernatant liquid was 
applied to previously conditioned end capped C6, C18 and C8/SCX solid phase 
extraction columns. The columns were washed, dried, and eluted with various 
solvents systems. The eluants were collected and evaporated. The residue was 
dissolved in 100 μl of aqueous 0.1% trifluoroacetic acid and analyzed by 
liquid chromatography using a C18 (4.6 × 150 mm, 5-μm particle size) column 
and monitored at 250 nm, using diode-array detection. A mobile phase 
consisting of methanol/0.1% TFA in distilled water (22:78 v/v) was employed. 
The data was collected and appraised. It was found that 3-ml 200-mg CEC06 
C6 (Hexyl end capped) solid-phase columns that had been washed with 3 × 3 
ml water and 3 × 3 ml acetonitrile and eluted with a solvent system consisting 
of 95:5 v/v acetonitrile/ammonia performed best. The linear range for this 
analysis was found to be from 0 to 10 ng/ml. The limit of detection was 
determined to be 1 ng/ml with a limit of quantification of 2.5 ng/ml. 
 
♦ George Lunn [40] [2005] has reported a liquid chromatographic determination 
of ropinirole hydrochloride in rat, dog and human plasma.  
 
Column  : 250 × 4.6 5 μm Ultrasphere ODS 
Mobile phase : ACN: 70 mM pH 3.8 ammonium formate buffer  
  (25:75) containing 0.3% EDTA and 0.005% SOS 
Flow rate  : 1ml/min 
Injection volume : 10–100 μl 
Detector  : UV 250 nm 
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Retention time  : 9.4 min 
Internal standard : 4-(2-di-N, N-propylaminoethyl)-7-methoxy-2-(3H)-   
     Indoline HCl (11.5 min) 
Limit of detection : 5 ng/ml 
Limit of quantitation : 10 ng/ml 
♦ Pavel Coufal et al. [41] [1999] have reported a Capillary liquid 
chromatography (CLC) for the separation and quantification of ropinirole and 
its five related impurities, potentially formed during its synthesis. A 
simultaneous optimization of three mobile phase parameters, i.e., pH, buffer 
concentration and acetonitrile content was performed employing an 
experimental design approach which proved a powerful tool in method 
development. The retention factors of the investigated substances in different 
mobile phases were determined. Baseline resolution of the six substances on a 
C18 reversed stationary phase was attained using a mobile phase with an 
optimized composition [acetonitrile-8.7 mM 2-(N-morpholino) ethanesulfonic 
acid adjusted to pH 6.0 (55:45, v/v)]. It was shown that CLC, operated in the 
isocratic mode under the mobile phase flow-rate of 4μl/min, could determine 
the level of these impurities, down to a level of 0.06% of the main component 
within 25 min. 
♦ SB Bari et al. [42] [2011] have developed and ratified a TLC/densitometry of 
ropinirole hydrochloride as a bulk drug. The separation was achieved on TLC 
aluminium plates precoated with silica gel 60F-254 as the stationary phase 
using chloroform: acetone: triethylamine (3.5:1.5:0.2 v/v) as mobile phase 
and densitometry analysis at 250 nm. The system showed compact spot for 
ropinirole hydrochloride (Rf = 0.52 ± 0.02). The drug followed linearity in the 
concentration range 300 - 1800 ng per band (r2 = 0.9983 ± 0.0008). Drug was 
subjected to hydrolysis, oxidation and thermal degradation which indicate the 
drug is susceptible to hydrolysis, oxidation and heat and degraded product did 
not interfere with detection and assay of ropinirole hydrochloride. Statistical 
analysis proved that the method was repeatable, selective and accurate for the 
estimation of ropinirole hydrochloride. 
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♦ Gulam Mustafa et al. [43] [2011] have developed and validated a stability-
indicating high-performance thin-layer chromatographic (HPTLC) method for 
analysis of ropinirole HCl as per the ICH guidelines. The method employed 
the mobile phase, toluene-ethyl acetate-6M ammonia solution (5:6:0.5, v/v/v). 
Densitometric analysis of ropinirole HCl was carried out in the absorbance 
mode at 250 and 254 nm. Compact spots for ropinirole HCl were found at Rf 
value of 0.58 ± 0.02. The linear regression analysis data for the calibration 
plots showed R2 = 0.9989 ± 0.0053 with concentration range of 100– 3000 ng 
spot-1. The method was validated for precision, accuracy, ruggedness, 
robustness, specificity, recovery, limit of detection (LOD) and limit of 
quantitation (LOQ). The LOD and LOQ were 12.95 and 39.25 ng spot-1 
respectively. Drug was subjected to acidic, alkaline, oxidative, dry heat, wet 
heat and photo degradation stress. All the peaks of degradation products were 
well resolved from the standard drug peak with significantly difference of 
retention factor. The acidic and alkaline stress degradation kinetics of 
ropinirole, was found to be in first order, showing high stability (t1/2,146.37 
hr-1; t0.9, 39.11 hr-1) in acidic medium and low stability (t1/2,97.67 hr-1; 
t0.9, 14.87 hr-1) in alkaline environment. 
♦ T. K. Ravi et al. [28] [2007] have developed a High Performance Liquid 
chromatography (HPTLC) for the determination of ropinirole hydrochloride 
in tablet. Solvent system used here was Methanol: Acetonitrile (8: 2 v/v) 
Detection wave length was found to be 254 nm. The linearity was found to be 
between 40 to 120 μg/ml. Since aripiprazole peak was well resolved from 
ropinirole hydrochloride peak and had good peak shape, aripiprazole was 
selected as an internal standard. This method could be applied for routine 
analysis of ropinirole hydrochloride in tablet dosage forms. 
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3.3 Electrophoretic techniques: 
♦ Pavel Coufal et al. [44] [1998] have reported a Capillary Zone Electrophoresis 
(CZE) method for the determination of the dissociation constants of ropinirole 
and five structurally related impurities, potentially formed during its synthesis 
and for separation and quantification of these substances. The dissociation 
constants obtained from the CZE measurements were confirmed by UV 
spectrophotometry for some of the test compounds, obtaining a good 
agreement between the values. Careful optimization of the running buffer 
composition permitted base-line resolution of the six compounds in a borate 
buffer containing acetonitrile and magnesium sulfate (a 100 mM borate buffer 
containing 30 mM MgSO4 and 20 vol. % of 4 acetonitrile). It was shown that 
CZE could determine the level of these impurities, down to a level of 0.05% of 
the main component within 15 min. 
 
3.4 Hyphenated Techniques:  
 
♦ D. Vijaya Bharathi et al. [45] [2009] have explicated a highly sensitive, rapid 
assay method has been developed and validated for the estimation of 
ropinirole (RPR) in human plasma with liquid chromatography coupled to 
tandem mass spectrometry with electro spray ionization in the positive-ion 
mode. A solid-phase process was used to extract RPR and citalopram (internal 
standard, IS) from human plasma. Chromatographic separation was operated 
with 0.2% ammonia solution: acetonitrile (20:80, v/v) at a flow rate of 0.50 
ml/min on a Hypurity C18 column with a total run time of 3.2 min. The 
MS/MS ion transitions monitored were 261.2 → 114.2 for RPR and 325.1 → 
209.0 for IS. Method validation and clinical sample analysis were performed 
as per FDA guidelines and the results met the acceptance criteria. The lower 
limit of quantitation achieved was 3.45 pg/ml and the linearity was observed 
from 3.45 to 1200 pg/ml. The intra-day and inter-day precisions were in the 
range of 4.71-7.98 and 6.56-8.31%, respectively. This novel method had been 
applied to a pharmacokinetic study of RPR in humans.  
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♦ Erin E. Chambers et al. [46] [2008] have evolved a rapid and sensitive SPE-
UPLC/MS/MS method for the determination of ropinirole hydrochloride in 
human plasma. Citalopram is used as an internal standard. 
LC Conditions: 
 Column   : C18 
 Mobile Phase   : 10mM NH4COOH (pH 9): CH3OH 
 Flow Rate   : 0.5ml/min 
 Injection volume  : 8.0 μl 
 Column Temperature  : 45˚C 
MS Conditions: 
 Ion Source    : Electro spray positive (ESI+) 
 Desolvation Temperature : 350˚ C 
 Cone gas flow   : 50 L/Hr 
 Desolvation gas flow  : 750 L/Hr 
 Collision cell pressure : 2.6 × 10(-3) mbar 
This method achieved a S/N of over 100: 1 at the required LLOQ of 
0.005ng/ml. the method meets the FDA requirements for linearity and 
excellent recovery for both analytes. This method enables researchers to 
obtain higher quality data faster in order to make critical project decisions. 
♦ Ai-Dong Wen et al. [47] [2007] have examined the effect of Madopar on the 
pharmacokinetics of ropinirole in healthy Chinese volunteers by using liquid 
chromatography tandem mass spectrometry (HPLC/MS/MS). A single dose of 
1mg ropinirole was given orally after administration of the placebo or 
Madopar (containing 200 mg levodopa and 50 mg benserazide) to six healthy 
males and six healthy females in a cross-over randomized study with a 
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minimum washout period of 8 days. Pharmacokinetic parameters were 
calculated for both treatments. Co administration of ropinirole and Madopar 
did not result in a notable change in rate or extent of availability of ropinirole, 
as shown by the ratios (90% confidence intervals) of 1.045 (0.900, 1.222) for 
Cmax (maximum plasma concentration) and 1.167 (1.086, 1.262) for AUC0–inf 
(the area under the concentration–time curve). Likewise, no significant 
difference in any of the other pharmacokinetic parameters [Tmax (the time 
needed to reach the Cmax), MRT (mean residence time), volume of distribution 
(V/F), and clearance (CL/F)] was observed between the treatment groups. No 
clinically relevant adverse effects were detected under either conditions and 
there are no pharmacokinetic grounds for adjusting the dose of ropinirole 
when given in combination with Madopar in Chinese patients. 
♦  William Edgemond et al. [48] [2007] have elaborated a LC-MS-MS method 
for the quantitation of ropinirole in human plasma. The method was validated 
with a quantitative range of 10.0 to 1000 pg/ml. EDTA human plasma (0.5 ml) 
was fortified with internal standard, ropinirole-D3 prior to extraction. After 
addition of sodium carbonate solution, the samples were extracted with ethyl 
acetate/cyclohexane, 9:1. After evaporating the solvent, the samples were 
reconstituted in mobile phase (A). A Hypersil GOLD PFP (3& [mu], 50x4.6 
mm) column was used, yielding a retention time of 1.5 minutes. A step 
gradient method was used to clear late eluters (mobile phase A consisted of 10 
mM ammonium acetate in 1:1, methanol: water and mobile phase B consisted 
of 100% methanol). Detection was carried out on a SCIEX API-5000 LC-MS-
MS in positive Ion Spray MRM mode. The transitions monitored were m/z 
261 & [rarr] 114 for ropinirole and m/z 264 & [rarr] 117 for ropinirole-D3. 
Three validation runs were performed on separate days. Precision (%CV) and 
accuracy (%bias) across all levels of the range were within & [plusmn] 8.0%. 
The precision and accuracy at the LLOQ was within & [plusmn] 9.0%. 
Extraction recovery ranged from 86% to 93%. No chromatographic 
interferences or matrix effects from six different lots of plasma were observed 
indicating the specificity of the method. Stability of ropinirole in plasma was 
established for 24 hours at room temperature, for 5 cycles of freezing and 
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thawing, and for 141 hours in the final extract. Long term stability of 
ropinirole in plasma was shown to be 80 days at –20 & [deg] C. The step 
gradient improved the robustness of the method. This method was successfully 
validated. The method proved rugged and sensitive in the determination of the 
concentrations of ropinirole in over 3400 samples generated from clinical 
trials. 
 
♦ Jignesh Bhatt et al. [49] [2006] have reported a rapid and robust liquid 
chromatography-mass spectrometry (LC-MS/MS) method for non-ergoline 
dopamine D (2)-receptor agonist, ropinirole in human plasma using Es-
citalopram oxalate as an internal standard. The method involves solid phase 
extraction from plasma, reversed-phase simple isocratic chromatographic 
conditions and mass spectrometric detection that enables a detection limit at 
picogram levels. The proposed method was validated with linear range of 20-
1,200 pg/ml. The extraction recoveries for ropinirole and internal standard 
were 90.45 and 65.42%, respectively. The R.S.D. % of intra-day and inter-day 
assay was lower than 15%. For its sensitivity and reliability, the proposed 
method was particularly suitable for pharmacokinetic studies. 
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4. AIM AND PLAN OF THE WORK 
4.1 Aim of the Work 
 The aim of the present study was to develop newer analytical methods for the 
estimation of ropinirole hydrochloride in bulk drug and its formulations. Ropinirole 
hydrochloride is an indole derivative and has di-alkylated tertiary amine in its side 
chain.  
 Literature survey reveals that only few analytical methods have been 
developed and reported for the estimation of ropinirole hydrochloride; they were UV, 
UPLC, HPLC, HPTLC, TLC, CZE, LC-MS and SPE-UPLC-MS.  
 As discussed earlier in drug profile, ropinirole hydrochloride is highly soluble 
in aqueous solvents. So the present study aims to develop newer and sensitive 
methods for the analysis of ropinirole hydrochloride using simple and economic 
aqueous solvents. 
 
4.2 Plan of the Work 
 Development of newer analytical methods as follows:  
♦ UV Spectrophotometric determination of ropinirole hydrochloride 
using 0.1 M acetic acid as solvent. 
♦ Extractive spectrophotometric estimation of ropinirole hydrochloride 
using 0.2 % picric acid in water used as a reagent. 
♦ RP - HPLC method for the estimation of ropinirole hydrochloride 
using ODS column as stationary phase and potassium dihydrogen 
phosphate buffer in 10 % ortho phosphoric acid (pH 3.3): acetonitrile 
(70: 30) as mobile phase.   
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5. METHODOLOGY 
5.1 UV Spectrophotometric Determination of Ropinirole Hydrochloride using  
0.1 M Acetic acid 
 
Apparatus/Instruments Used 
 UV- Visible double beam Spectrophotometer (Perkin Elmer EZ 301) 
 Analytical electronic weighing balance (Shimadzu) 
 Vortex mixer 
 
Solvents Used 
 Acetic acid - AR Grade 
 Water - Distilled Water  
 
Reference Standard 
 Ropinirole hydrochloride was obtained as a gift sample from East West 
Pharma Haridwar - 247 667, India. 
 
Tablet Formulations 
 Ropark film coated tablets – 2 mg (Sun Pharmaceuticals Industries Ltd) 
 Ropin film coated tablets – 2 mg (East West Pharma) 
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Preparation of 0.1 M Acetic acid in Water 
 It was prepared by diluting 5.7 ml of concentrated acetic acid in 1000 ml of 
distilled water. 
 
Preparation of standard stock solution 
Standard stock solution - I  
 Standard stock solution - I was prepared by dissolving 25 mg of ropinirole 
hydrochloride working standard in 25 ml of 0.1 M acetic acid to get a final 
concentration of 1 mg/ml. 
 
Standard stock solution - II 
 2 ml of standard stock solution I was taken and further diluted to 25ml with 
same solvent to get the final concentration of 80 μg/ml. 
  
Selection of Wavelength 
 2.5 ml of standard stock solution - II was pipetted out and diluted to 10ml with 
0.1 M acetic acid. Then this solution was scanned in the UV region of 200 - 400 nm to 
get absorption maximum (λmax). The drug was found to have a maximum absorbance 
at 250 nm in 0.1 M acetic acid and hence this wavelength was selected for further 
studies. The absorbance data were presented in table no.2 and absorption spectrum 
was shown in figure no.4. 
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Table no: 2 Data for the absorption spectrum of ropinirole hydrochloride using    
0.1 M acetic acid 
S.No Wavelength Absorbance 
1 200 3.000 
2 210 3.000 
3 220 0.711 
4 230 0.328 
5 240 0.502 
6 250* 0.625 
7 260 0.425 
8 270 0.140 
9 280 0.101 
10 290 0.056 
11 300 0.008 
12 310 0.004 
13 320 0.004 
14 330 0.003 
15 340 0.003 
16 350 0.002 
17 360 0.003 
18 370 0.003 
19 380 0.003 
20 390 0.004 
21 400 0.003 
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Figure no: 4 Absorption spectrum of ropinirole hydrochloride using                        
0.1 M acetic acid  
 
 
 
 
Table no: 3 System Parameters 
 
 
 
 
 
 
 
 
 
 
Wavelength Scan 
Data Mode Absorbance 
Start WL (nm) 400.00 
Stop WL (nm) 200.00 
Scan Speed (nm/min) 100 
Slit Width (nm) 1.5 
Path Length (nm) 10.0 
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Beer’s law plot  
This law states that, when a beam of monochromatic radiation is passed through a 
solution of an absorbing substance, the rate of increase of intensity of radiation of 
thickness of the absorbing solution proportional to the intensity of incident radiation 
as well as the concentration of the solution. 
Mathematically, this law was stated as  
- dI/dx = k’ Ic 
Construction of calibration curve 
Aliquots of working standard stock solution - II ranging from (0.5ml to 4ml) were 
transferred into a series of 10ml volumetric flasks. Then the volume was made up 
with 0.1 M acetic acid. The absorbance of resulting solution of different concentration 
was measured at 250nm against the solvent blank. Calibration curve was constructed 
by plotting absorbance vs. concentration. 
Dilution chart  
Dilution chart of calibration curve 
25mg of pure Ropinirole HCl    * 25 ml (stock solution - I 1 mg/ml) 
                                                                                                                      * 
                2 ml 
                                                                                       * 
 
                   25 ml (stock solution-II, 80 μg/ml) 
   
              
0.5 ml            1 ml            1.5 ml       2 ml           2.5         3 ml           3.5 ml       4 ml 
      *                  *                    *                *              *               *                *                * 
10 ml        10 ml      10 ml  10 ml     10 ml        10 ml          10 ml      10 ml       
(4μg/ml,    8μg/ml, 12μg/ml, 16 μg/ml, 20 μg/ml, 24 μg/ml, 28 μg/ml, 32 μg/ml) 
* 0.1 M Acetic acid 
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Table no: 4 Data for calibration curve of ropinirole hydrochloride using                 
0.1 M acetic acid  
Concentration (μg/ml) Absorbance 
4 0.126 
8 0.255 
12 0.380 
16 0.494 
20 0.631 
24 0.758 
28 0.877 
32 1.002 
 
Figure no: 5 Calibration curve of ropinirole hydrochloride using                             
0.1 M acetic acid  
 
 
Assay 
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Preparation of standard solution 
From the working standard stock solution – II 2.5 ml was taken and further diluted to 
10ml with same solvent to get the final concentration of 20μg/ml. The absorbance of 
final solution was measured at 250nm against the solvent blank. 
Dilution chart 
25mg of pure Ropinirole HCl    * 25 ml (stock solution-I, 1000 μg/ml) 
                                                                                                                              
                    2 ml 
                                                                                                              *           
      25 ml (stock solution-II, 80 μg/ml) 
                                                                                                    
         
                         2.5 ml   
                                                                                                   * 
                                                                                                  
                                                                                                   10 ml (20μg/ml) 
 
* 0.1 M Acetic acid 
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Preparation of test solution 
Twenty tablets (2 mg) of ropinirole hydrochloride were accurately weighed and 
grounded to fine powder. Ropinirole hydrochloride tablet powder equivalent to the 
label claim was accurately weighed and dissolved in 0.1 M acetic acid using vortex 
mixer and then the solution was diluted to 100ml to get a final concentration of 
20µg/ml using same solvent. Then the final solution was filtered and the absorbance 
of resulting solution was measured at 250nm against the solvent blank. 
Dilution chart 
2 mg equivalent of ropinirole HCl tablet powder  
                     * 
      
     100 ml (20 μg/ml) 
 
* 0.1 M Acetic acid 
 
Calculation: 
 Using the absorbance of the standard and sample solution, the content of tablet 
was calculated as follows. 
 
The content of ropinirole HCl present in each tablet of average weight = 
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Table no: 5 Quantitative estimation of Brand I - Ropark 
 
Label claim - 2 mg                Average weight - 0.1431 g 
S.No Wt of std 
drug (g) 
Abs. of std Wt of tab. 
powder (g)
Abs. of 
test 
Amount of 
drug/tab 
(mg) 
% Label 
claim 
1 0.0245 0.631 0.1196 0.615 2.004 100.20 % 
2 0.0245 0.631 0.1283 0.656 1.993 99.65 % 
3 0.0245 0.631 0.1352 0.697 2.010 100.50 % 
4 0.0245 0.631 0.1380 0.714 2.017 100.85 % 
5 0.0245 0.631 0.1298 0.665 1.997 99.85 % 
 
Table no: 6 Quantitative estimation of Brand II- Ropin 
 
  Label claim - 2 mg                Average weight - 0.1375 g 
S.No Wt of std 
drug (g) 
Abs. of std Wt of tab. 
powder (g)
Abs. of 
test 
Amount of 
drug/tab 
(mg) 
% Label 
claim 
1 0.0248 0.642 0.1372 0.769 2.040 102 % 
2 0.0248 0.642 0.1334 0.749 2.067 103.35 % 
3 0.0248 0.642 0.1428 0.781 2.013 100.65 % 
4 0.0248 0.642 0.1390 0.776 2.055 102.75 % 
5 0.0248 0.642 0.1370 0.762 2.048 102.40 % 
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Interference studies 
 The interference studies of additives used in the formulation of tablet were 
done by distributing them individually in 0.1 M acetic acid and set aside for ten 
minutes before filtering. The filtrate was diluted and preceded as per tablet assay. The 
absorbance of resulting solution was measured at 250nm against the solvent blank. 
 This procedure was repeated five times of each additive and the average value 
for each additive was given the following table no. 7 
 
Table no: 7 Data for the interference studies 
Name of the excipients Absorbance at 250 nm 
Talc 0.001 
Lactose 0.002 
Starch 0.001 
Mg. Sterate 0.003 
 
The results show that excipients have no effect in the absorption characteristics of the 
drug. 
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Recovery studies (Accuracy) 
Procedure 
 The tablet powder equivalent to about 1 mg of ropinirole hydrochloride was 
weighed accurately and transfer to 100 ml volumetric flask. A known volume of 
standard stock solution of 1 mg/ml of pure ropinirole hydrochloride was added to the 
volumetric flask and 30 ml of 0.1 M acetic acid was added and mixed thoroughly 
using vortex mixer. Then it was diluted to 100 ml using same solvent and it was 
filtered and absorbance of final solution was measured at 250 nm against the solvent 
blank.  
 The percentage recovery was calculated and the procedure was repeated five 
times for each brand of tablet powder. The result of the recovery studies were given in 
the table no.8 & 9 
 
 
Dilution chart 
1 mg equivalent of ropinirole HCl tablet 
                                                                     *    1ml of 1mg/ml std drug stock solution 
                                                                             * 0.1 M acetic acid 
 
                                              100 ml (20 μg/ml) 
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Table no: 8 Recovery studies for brand I - Ropark 
S.No Wt of tab. 
powder (g) 
Amt of std drug 
added (mg/ml) 
Absorbance Amt recovered 
(mg) 
% 
recovery 
1 0.07130 0.992 0.676 0.978 98.58 % 
2 0.07092 0.992 0.671 0.968 97.58 % 
3 0.07395 0.992 0.691 0.984 99.19 % 
4 0.07254 0.992 0.685 0.986 99.39 % 
5 0.07084 0.992 0.669 0.963 97.07 % 
 
 
 
Table no: 9 Recovery studies for brand II - Ropin 
S.No Wt of tab. 
powder (g) 
Amt of std 
added (mg/ml) 
Absorbance Amt recovered 
(mg) 
% 
recovery 
1 0.07081 0.980 0.711 0.961 98.07 % 
2 0.06985 0.980 0.702 0.953 97.24 % 
3 0.07158 0.980 0.719 0.972 99.18 % 
4 0.07237 0.980 0.723 0.971 99.08 % 
5 0.07084 0.980 0.709 0.954 97.34 % 
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Precision 
 The precision of an analytical procedure expresses the closeness of agreement 
between a series of measurements obtained from multiple sampling of the same 
homogenous sample under prescribed condition. 
 It is usually expressed as standard deviation. It is a measure of degree of 
reproducibility of analytical method under normal operation. 
 Standard deviation (SD) = √  
Where, 
  SD – Standard deviation 
  x – Observed value 
   - Arithmetic mean 
  n – Number of observations 
 
The square of standard deviation is called variance. The precision is assessed by co-
efficient of variation which is related to standard deviation. 
 
 Co-efficient of variation (% RSD) =  
 Where, 
  SD – standard deviation 
   - Arithmetic average 
  RSD – relative standard deviation 
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 Standard Error of Mean (SEM) =  
Where, 
σM - Standard error of the mean 
σ  - The standard deviation of the original distribution 
N - The sample size 
√N - Root of the sample size 
 
 
The precision study of this method was done by the data obtained from the assay 
results shown in the table. 10 
 
 
 
Table no: 10 Data for precision study 
S.No Name of 
tablet 
Std 
deviation 
Co-efficient of 
variation (% RSD) 
SEM 
1 Ropark 0.4840 0.4829 0.2164 
2 Ropin 1.013 0.9909 0.4529 
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5.2 Extractive Spectrophotometric Determination of Ropinirole hydrochloride 
using 0.2 % Picric acid 
 
Apparatus/Instruments Used 
 UV- Visible double beam Spectrophotometer (Perkin Elmer EZ 301) 
 Analytical electronic weighing balance (Shimadzu) 
 Vortex mixer 
 
Solvents and Reagents Used 
 Acetic acid - AR Grade 
 Chloroform - AR Grade 
 Picric acid - AR Grade 
 Water - Distilled Water  
 
Reference Standard 
 Ropinirole hydrochloride was obtained as a gift sample from East West 
Pharma Haridwar - 247 667, India. 
 
Tablet Formulations 
 Ropark film coated tablets – 2 mg (Sun Pharmaceuticals Industries Ltd) 
 Ropin film coated tablets – 2 mg (East West Pharm 
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Chemistry of Picric acid 
 Chemical Structure  
 
NO2
OH
NO2
O2N
 
 
 CAS Registry Number - 88-89-1 
 
 Appearance - Bright yellow, crystalline powder or yellow prisms 
 
 IUPAC Name - 2, 4, 6 - Trinitrophenol 
 
 Molecular Formula - C6H3N3O7 
 
 Molar Mass - 229.11 g mol-1 
 
 Solubility - Soluble in hot water 
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Preparation of 0.1 M Acetic acid  
 It was prepared by diluting 5.7 ml of concentrated acetic acid in 1000 ml of 
distilled water. 
Preparation of 1 % Potassium hydrogen phthalate 
 It was prepared by dissolving 1 g of potassium hydrogen phthalate in 100 ml 
of distilled water. 
Preparation of 0.2 % Picric acid 
 It was prepared by dissolving 0.2 g of picric acid in 100 ml of hot distilled 
water 
Preparation of standard stock solution 
Standard stock solution - I  
Standard stock solution - I was prepared by dissolving 40 mg of ropinirole 
hydrochloride working standard in 100 ml of 0.1 M acetic acid to get a final 
concentration of 400 μg/ml. 
Standard stock solution - II 
From the standard stock solution - I 5 ml was taken and further diluted to 50ml with 
same solvent to get the final concentration of 40 μg/ml. 
Absorption spectra of colored species 
 2 ml of standard stock solution II was pipetted out and transferred in to a 
separating funnel followed by the addition of 2 ml of 0.2 % picric acid was added. 
The drug dye complex in aqueous phase was extracted with two successive quantities 
of chloroform. The combined chloroform extract was diluted to 10 ml with 
chloroform. The absorption spectra of the final solution were scanned in the range of 
300 to 500 nm against the reagent blank. The absorbance data were presented in table 
no. 11 and absorption spectrum was shown in figure no. 6 
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Table no: 11 Data for the absorption spectrum of ropinirole hydrochloride using   
0.2 % picric acid 
S.No Wavelength Absorbance 
1 300 0.115 
2 310 0.155 
3 320 0.224 
4 330 0.302 
5 340 0.359 
6 350* 0.361 
7 360 0.302 
8 370 0.228 
9 380 0.183 
10 390 0.171 
11 400 0.175 
12 410* 0.175 
13 420 0.163 
14 430 0.126 
15 440 0.075 
16 450 0.034 
17 460 0.012 
18 470 0.004 
19 480 0.002 
20 490 0.002 
21 500 0.002 
 
Chapter 5                                                                                                                           Methodology 
 
Dept. of Pharmaceutical Analysis  57 
 
 
Figure no: 6 Absorption spectrum of ropinirole hydrochloride using      
0.2 % picric acid 
 
 
 
 
Table no: 12 System Parameters 
 
 
 
 
 
 
 
 
 
 
Wavelength Scan 
Data Mode Absorbance 
Start WL (nm) 500.00 
Stop WL (nm) 300.00 
Scan Speed (nm/min) 100 
Slit Width (nm) 1.5 
Path Length (nm) 10.0 
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Effect of reagent concentration  
 Choosing of correct reagent concentration is a significant characteristic 
criterion in the colorimetric determination. The optimal concentration was 
predetermined by constructing the calibration curve. The calibration curve was 
constructed by treating the drug in the concentration range of 2 - 10 μg/ml with 2 ml 
of different concentration of reagent i.e. 0.1 %, 0.2 %, 0.3 % picric acid. The readings 
were tabulated in the table no: 13 and graphically shown in the figure no: 7  
 
Table no: 13 Data for calibration curve using different reagent concentration 
 
Drug concentration 
(μg/ml) 
Absorbance at 410 nm 
0.1 % 0.2 % 0.3 % 
2 0.053 0.057 0.059 
4 0.104 0.112 0.121 
6 0.152 0.167 0.182 
8 0.186 0.218 0.253 
10 0.202 0.276 0.317 
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Figure no:  7 Calibration curve for ropinirole hydrochloride using 
different concentration of picric acid regent 
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Effect of volume of reagent  
 Addition of correct volume of reagent was an important aspect in this 
experiment. The optimum amount of reagent was fixed by constructing calibration 
curve. The calibration curve was prepared by employing the drug in the concentration 
range of 2-10 μg/ml with different volume of reagent i.e. 1 ml, 2 ml, 3ml with same 
reagent concentration (0.2 % picric acid). The results were recorded in table no. 14 
and graphically shown in figure no. 8 
 
 
Table no: 14 Data for the calibration curve for drug with different volume of        
0.2 % picric acid reagent 
Drug 
Concentration 
(μg/ml) 
Absorbance at 410 nm 
0.5 ml 1 ml 1.5 ml 
2 0.052 0.057 0.062 
4 0.105 0.112 0.124 
6 0.151 0.167 0.180 
8 0.184 0.218 0.256 
10 0.200 0.276 0.315 
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Figure no:  8 Calibration curve for ropinirole hydrochloride using different 
volume of 0.2 % picric acid regent 
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Fixation of various parameters  
I) λmax (wavelength maximum) 
 The absorption spectral data showed that the maximum absorbance was 
observed at 350 and 410 nm. 
II) Construction of calibration curve 
Aliquots of working standard stock solution - II ranging from (0.5 ml to 2.5 ml) were 
transferred into a series of separating funnel followed by the addition of 2 ml of 0.2 % 
picric acid. The drug dye complex in aqueous phase was extracted with two 
successive quantities of chloroform. The combined chloroform extract was diluted to 
10 ml with chloroform. The absorbance of the final solution was measured at 410 nm 
against the reagent blank. Calibration curve was constructed by plotting absorbance 
vs. concentration. Data for calibration curve were presented in table no.15 and 
calibration curve was shown in figure no.9 
Dilution chart of calibration curve 
40mg of pure Ropinirole HCl           *      100 ml (stock solution - I, 400 μg/ml) 
                                                                                                            
                                                                                                       5ml                                                      
                                                                                                 * 
                                 50 ml (stock solution-II, 40 μg/ml) 
   
        0.5 ml                 1 ml             1.5 ml                  2 ml               2.5 ml
           
   **                         **                       **                          **                          ** 
     10 ml                   10 ml                  10 ml                   10 ml                    10 ml 
 (2 μg/ml)              (4 μg/ml)            (6 μg/ml)            (8 μg/ml)         (10 μg/ml)  
 
* 0.1 M acetic acid  
** 2 ml of 1 % potassium hydrogen phthalate 
solution, 1 ml of 0.2 % picric acid & extracted 
with 5 ml chloroform and volume was made up 
to 10 ml with chloroform.    
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Table no: 15 Data for calibration curve of ropinirole hydrochloride using              
0.2 % picric acid reagent 
Concentration (μg/ml) Absorbance 
2 0.057 
4 0.112 
6 0.167 
8 0.218 
10 0.276 
 
 
Figure no: 9 Calibration curve of ropinirole hydrochloride using                                 
0.2 % picric acid reagent 
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IV) Stability of color 
 The stability of the color is one of the aspects that should be considered in 
colorimetric determination. The color should be stable for reasonable time. 
The color stability of the drug - picric acid complex was studied for the drug 
concentration in the range of 2 - 10 μg/ml.  The absorption of the final solution was 
measured at 410 nm against reagent blank. The readings were taken at 10 minutes 
intervals of time up to 60 minutes and results were tabulated in the table no.15 
 
Table no: 16 Data for color stability of drug-picric acid complex 
 
Drug conc. 
(μg/ml) 
Time and Absorption (minutes) 
0 10 20 30 40 50 60 
2 0.057 0.057 0.055 0.058 0.058 0.061 0.061 
4 0.112 0.112 0.111 0.111 0.113 0.114 0.113 
6 0.167 0.169 0.168 0.167 0.168 0.170 0.169 
8 0.218 0.218 0.217 0.217 0.219 0.220 0.220 
10 0.276 0.275 0.277 0.279 0.278 0.281 0.281 
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Assay 
Preparation of standard solution 
From the working standard stock solution – II 2 ml was taken and transferred 
in to a separating funnel followed by the addition of 2 ml of 1 % potassium hydrogen 
phthalate solution and 1 ml of 2 % picric acid solution. The drug-picric acid complex 
was extracted with two successive quantities of chloroform. Then the combined 
chloroform extract was further diluted to 10ml with chloroform to get the final 
concentration of 8 μg/ml. The absorbance of final solution was measured at 410 nm 
against the reagent blank. 
 
Dilution chart 
40 mg of pure Ropinirole HCl    * 100 ml (stock solution-I, 400 μg/ml) 
                                                                                        
                                                                                                          5 ml 
                                                                                                                *           
      50 ml (stock solution-II, 40 μg/ml) 
                                                                                                   
         
                             2 ml   
                                                                                                               
   ** 
                                                                                                 10 ml (8μg/ml) 
 
 
 
* 0.1 M acetic acid  
** 2 ml of 1 % potassium hydrogen phthalate 
solution, 1 ml of 0.2 % picric acid & extracted 
with 5 ml chloroform and volume was made up 
to 10 ml with chloroform.    
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Preparation of test solution 
Twenty tablets (1 mg) of ropinirole hydrochloride were accurately weighed 
and grounded to fine powder and dissolved in 0.1 M acetic acid using vortex mixer. 
Then the solution was diluted to 25 ml to get a drug concentration of 40µg/ml using 
0.1 M acetic acid and resulting solution was filtered to remove excipients. From this 2 
ml was transferred in to a separating funnel followed by the addition of 2 ml of 1 % 
potassium hydrogen phthalate solution and 1 ml of 2 % picric acid. The drug-picric 
acid complex was extracted by using two successive quantities of chloroform.  The 
combined chloroform extract was collected in a 10 ml volumetric flask and volume 
was made up with chloroform. Finally the absorbance of resulting solution was 
measured at 410nm against the reagent blank.  
Dilution chart 
1 mg equivalent of ropinirole HCl tablet powder              *                25 ml (40 μg/ml) 
 
                                                                                                                                           
      
                                                                 2 ml 
                                                                      
 **        ** 
                                                             
                                                                                                                     
                                                                                                               10 ml (8 μg/ml)                         
                                                             
 
 
 
* 0.1 M acetic acid  
** 2 ml of 1 % potassium hydrogen phthalate 
solution, 1 ml of 0.2 % picric acid & extracted 
with 5 ml chloroform and volume was made up 
to 10 ml with chloroform.   
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Table no: 17 Quantitative estimation of Brand I - Ropark 
Label claim - 2 mg                Average weight - 0.1431 g 
S.No Wt of std 
drug (g) 
Abs. of std Wt of tab. 
powder (g)
Abs. of 
test 
Amount of 
drug/tab 
(mg) 
% Label 
claim 
1 0.0402 0.215 0.0695 0.239 2.017 100.85 % 
2 0.0402 0.215 0.0681 0.235 2.024 101.20 % 
3 0.0402 0.215 0.0693 0.236 1.998   99.90 % 
4 0.0402 0.215 0.0704 0.238 1.983   99.15 % 
5 0.0402 0.215 0.0691 0.237 2.012 100.60 % 
 
Table no: 18 Quantitative estimation of Brand II- Ropin 
Label claim - 2 mg      Average weight - 0.1375 g 
S.No Wt of std 
drug (g) 
Abs. of std Wt of tab. 
powder (g)
Abs. of 
test 
Amount of 
drug/tab 
(mg) 
% Label 
claim 
1 0.0404 0.219 0.0656 0.235 1.996 99.80 % 
2 0.0404 0.219 0.0675 0.238 1.961 98.05 % 
3 0.0404 0.219 0.0649 0.232 1.988 99.40 % 
4 0.0404 0.219 0.0653 0.232 1.976 98.80 % 
5 0.0404 0.219 0.0687 0.241 1.951 97.55 % 
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Interference studies 
 The interference studies of additives used in the formulation of tablet were 
done by distributing them individually in 0.1 M acetic acid and set aside for ten 
minutes before filtering. The filtrate was diluted and preceded as per tablet assay. The 
absorbance of resulting solution was measured at 410nm against the reagent blank. 
 This procedure was repeated five times of each additive and the average value 
for each additive was given the following table. 
 
Table no: 19 Data for the interference studies 
Name of the excipients Absorbance at 410 nm 
Talc 0.003 
Lactose 0.001 
Starch 0.002 
Mg. Sterate 0.003 
 
The results show that excipients have no effect in the absorption characteristics of the 
drug. 
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Recovery studies (Accuracy) 
Procedure 
 The tablet powder equivalent to about 1 mg of ropinirole hydrochloride was 
weighed accurately and transfer to 50 ml volumetric flask. A known volume of 
standard stock solution of 1 mg/ml of pure ropinirole hydrochloride was added to the 
volumetric flask and 15 ml of 0.1 M acetic acid was added and mixed thoroughly 
using vortex mixer. Then it was diluted to 50 ml using 0.1 M acetic acid and it was 
filtered. 2 ml of filtrate was transferred in to a separating funnel. The absorbance of 
final solution was measured at 410 nm against the reagent blank.  
 The percentage recovery was calculated and the procedure was repeated five 
times for each brand of tablet powder. The result of the recovery studies was given in 
the table no. 20 & 21 
Dilution chart 
1 mg equivalent of ropinirole HCl tablet powder + 1 ml of 1 mg/ml std stock soln 
   * 
                                                                                                
                                                                                                   50 ml (40 μg/ml) 
                                                                                                                                                                  
                                                              
                                                                                                  2 ml 
                                                                                                                        
                                                                                                                   **   
 
                                                                                                      10 ml (8 μg/ml) 
 
* 0.1 M acetic acid  
** 2 ml of 1 % potassium hydrogen phthalate 
solution, 1 ml of 0.2 % picric acid & extracted
with 5 ml chloroform and volume was made up 
to 10 ml with chloroform.   
Chapter 5                                                                                                                           Methodology 
 
Dept. of Pharmaceutical Analysis  70 
 
Table no: 20 Recovery studies for brand I - Ropark 
S. No Wt of tab. 
powder 
Amt of std 
added 
(mg/ml) 
Absorbance Amt 
recovered 
(mg) 
% recovery 
1 0.0734 1.012 0.229 1.006 99.40 % 
2 0.0715 1.012 0.226 1.007 99.59 % 
3 0.0746 1.012 0.228 0.978 96.64 % 
4 0.0718 1.012 0.224 0.984 97.23 % 
5 0.0749 1.012 0.232 1.011 99.90 % 
 
Table no: 21 Recovery studies for brand II - Ropin 
S. No Wt of tablet 
powder 
Amt of std 
added 
(mg/ml) 
Absorbance Amt 
recovered 
(mg) 
% recovery 
1 0.0687 0.994 0.222 0.953 95.89 % 
2 0.0678 0.994 0.221 0.976 98.18 % 
3 0.0665 0.994 0.218 0.968 97.38 % 
4 0.0696 0.994 0.226 0.993 99.89 % 
5 0.0675 0.994 0.221 0.990 99.59 % 
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Precision 
 The precision study of this method was done by the data obtained from the 
assay results shown in the table no. 22 
Table no: 22 Data for precision 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S. No. Name of tablet Std deviation Co-efficient of 
variation (% RSD) 
SEM 
1 Ropark 0.8181 0.8153 0.3659 
2 Ropin 0.9291 0.9411 0.4155 
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5. 3 RP-HPLC Method for the Determination of Ropinirole hydrochloride 
 
Apparatus/Instruments Used 
 HPLC Separation Module (Perkin Elmer) 
 Analytical electronic weighing balance (Shimadzu) 
 Vortex Mixer 
 Sonicator 
 Micropipette 
 pH meter 
 Membrane filter 
Solvents and Reagents Used  
 Water - HPLC grade 
 Potassium dihydrogen phosphate - HPLC grade 
 Acetonitrile - HPLC grade 
Reference Standard 
 Ropinirole hydrochloride was obtained as a gift sample from East West 
Pharma Haridwar - 247 667, India. 
Tablet Formulations  
 Ropark film coated tablets - 2 mg (Sun Pharmaceuticals Industries Ltd) 
 Ropark film coated tablets - 2 mg (East West Pharma) 
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Preparation of 20 mM potassium dihydrogen phosphate buffer 
 It is prepared by dissolving 2.7218 g in 1000 ml of HPLC grade water and the 
pH was adjusted to 3.3 with 10 % ortho phosphoric acid. 
Preparation of mobile phase 
 Mobile phase was prepared by mixing 70:30 ratio volumes of 20 mM 
KH2PO4: ACN. This mobile phase was filtered through 0.45 μ membrane filter paper 
and degassed in ultrasonicator bath for 10 minutes 
Preparation standard stock solutions 
Standard stock solution I 
 Standard stock solution - I was prepared by dissolving 10 mg of ropinirole 
hydrochloride working standard in 10 ml of mobile phase mixture to get a final 
concentration of 1000 μg/ml. 
Standard stock solution II 
 From the standard solution - I, 1 ml was taken and further diluted to 10 ml 
with mobile phase mixture to get the final concentration of 100 μg/ml. 
 Selection of stationary phase  
 From the literature survey, it was found that octadecyl silane column (C18) can 
be appropriately used for the separation of ropinirole hydrochloride. 
Selection of analytical wavelength 
 From the UV spectrum of the compound, the maximum absorbance of 
Ropinirole hydrochloride was found to be 250 nm and this wavelength was suitable 
for detection. So the appreciable absorbance for the drug was found at 250 nm.  
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CHROMATOGRAPHIC CONDITIONS: 
Optimized conditions for the determination of Ropinirole hydrochloride by developed 
HPLC method was shown as follows: 
Column   : Kromosil C18, [5μ, 250 x 4.60 mm] 
Mobile phase    : 20 mM KH2PO4: ACN (70: 30) pH 3.3 
Flow rate   : 1 ml/min 
Detector   : UV detector 
Injection volume   : 20 μl 
Run time   : 7.5 min 
Mode of elution  : Isocratic 
Detection Wavelength : 250 nm 
 
Construction of linearity 
 The linear concentration range was established for the drug solution in the 
concentration range of 4 - 16 μg/ml of ropinirole hydrochloride. 0.4 - 1.6 ml of stock 
solution II was pipetted in to 10 ml volumetric flask and diluted to 10 ml to get the 
desired concentration range. The calibration curve for ropinirole hydrochloride was 
constructed by plotting the peak area against the concentration. Correlation coefficient 
(r), y intercept, slope of regression line was calculated. The recorded data were shown 
in the table no: 22 and linearity graph was shown in the figure no: 10 
 
 
 
 
 
Chapter 5                                                                                                                           Methodology 
 
Dept. of Pharmaceutical Analysis  75 
 
Dilution chart  
 
 
10 mg of pure Ropinirole HCl         *           10 ml (stock solution - I, 1000 μg/ml) 
                                                                                                       
                                                                                                        1 ml   
   * 20 mM KH2PO4: ACN (70: 30)                                                    * 
                                                                                            10 ml (100 μg/ml) 
         
 
  
                              0.4 ml                   0.8 ml                1.2 ml                    1.6 ml 
                                   *                             *                         *                          * 
                               10 ml                     10 ml                   10 ml                10 ml 
                             (4 μg/ml)                (8 μg/ml)            (12 μg/ml)       (16 μg/ml) 
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Table no: 23 Data for linearity curve for Ropinirole hydrochloride 
 
S.No Conc. (μg/ml) Peak area 
1 4 135505.22 
2 8 270912.44 
3 12 404413.65 
4 16 539824.88 
 
 
 
 
Figure no: 10 Linearity curve of Ropinirole hydrochloride 
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Chromatogram: 1 
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Chromatogram: 2 
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Chromatogram: 3 
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Chromatogram: 4 
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Chromatogram: 5 
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ASSAY 
Preparation of standard solution 
 From the working standard solution - II, 0.8 ml was pipetted out in to a 10 ml 
volumetric flask and the volume was made up with mobile phase mixture containing 
20 mM KH2PO4: ACN (70: 30) to get a final concentration of 8 μg/ml. 
 20 μl of the above solution was injected in triplicate at an interval of 7.5 min 
to ensure complete elution of earlier injection. The peak area was measured and 
recorded. 
Dilution chart  
10 mg of pure Ropinirole HCl         *           10 ml (stock solution - I, 1000 
μg/ml) 
                                                                                                  
                                                                                    1 ml   
  * 20 mM KH2PO4: ACN (70: 30)                                   * 
 
                                                                        10 ml (stock soln - II, 100 μg/ml) 
                                                                                                  
 
                                                                                     0.8 ml 
                                                                                           * 
 
                                                                                   10 ml (8 μg/ml) 
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Preparation of test solution  
 Twenty tablets (2 mg) of Ropinirole hydrochloride were accurately weighed 
and grounded to fine powder. Ropinirole hydrochloride tablet powder equivalent to 1 
mg was accurately weighed and dissolved in mobile phase using vortex mixture and 
the volume was made up to 10 ml with mobile phase to get a concentration of 100 
μg/ml. Then this solution was filtered, from this 0.8 ml o0f filtrate was pipetted out 
into 10 ml of volumetric flask and the volume was made up to 10 ml with mobile 
phase solution to get a final concentration of 8 μg/ml.    
  20 μl of the above solution was injected in triplicate at an interval of 7.5 min 
to ensure complete elution of earlier injection. The peak area was measured and 
recorded. 
Dilution chart  
1 mg equivalent of tablet powder           *              10 ml (100 µg/ml) 
  
                                                                                          
                                                                                   0.8 ml 
                                                                                           * 
 
                                                                                 10 ml (8 µg/ml) 
*   20 mM KH2PO4: ACN (70: 30)    
Assay calculation 
The content of ropinirole HCl present in each tablet of average weight = 
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Table no: 24 Quantitative estimation of Brand I - Ropark 
Label claim - 2 mg                Average weight - 0.1431 g 
S.No 
Standard Tablet 
Amount of 
drug/tab 
(mg) 
% Label 
claim 
Wt of 
Std 
drug 
(mg) 
Peak area
Wt of 
tab. 
powder 
(mg) 
Peak area
1 9.8 272512.44 70.7 312426.45 2.003 100.15 % 
2 9.8 272512.44 71.6 312916.58 1.988 99.06 % 
3 9.8 272512.44 70.9 312469.23 1.997 99.85 % 
4 9.8 272512.44 71.2 312522.13 1.989 99.45 % 
5 9.8 272512.44 68.3 312389.23 2.042 102.10 % 
 
 
Table no: 25 Quantitative estimation of Brand II- Ropin 
Label claim - 2 mg               Average weight - 0.1375 g 
S.No 
Standard Tablet 
Amount of 
drug/tab 
(mg) 
% Label 
claim 
Wt of 
Std 
drug 
(mg) 
Peak area
Wt of 
tab. 
powder 
(mg) 
Peak area
1 9.8 272512.44 66.2 311720.35 2.042 102.10 % 
2 9.8 272512.44 67.4 312141.18 2.009 100.45 % 
3 9.8 272512.44 65.8 311410.18 2.053 102.65 % 
4 9.8 272512.44 67.1 312128.30 2.018 100.90 % 
5 9.8 272512.44 66.0 311568.24 2.047 102.35 % 
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Chromatogram: 6 
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Chromatogram: 7 
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Chromatogram: 8 
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Recovery Studies (Accuracy) 
 The recovery experiment was performed for 2 brands of tablet. Tablet powder 
equivalent 0.8 mg of ropinirole hydrochloride was weighed. A known volume of 
standard solution (0.2 mg/ml) of pure sample of ropinirole hydrochloride was added 
to the tablet powder. Then the dilution was made similar to assay formulation. The 
recovery percentage was calculated. It was repeated for 5 times. The recovery studies 
were shown in table: 26 & 27 
 
Dilution chart  
0.8 mg equivalent of tab powder + 1ml of 0.2 mg/ml of pure ropinirole HCl   
 * 
             
      10 ml (100 μg/ml) 
 
 
                                                               0.8 ml  
                                                                      * 
 
 10 ml (8 μg/ml) 
                                           
*   20 mM KH2PO4: ACN (70: 30)    
 
 
 
 
 
Chapter 5                                                                                                                           Methodology 
 
Dept. of Pharmaceutical Analysis  89 
 
Table no: 26 Recovery studies for brand I - Ropark 
S.No Wt of test 
(g) 
Amt of std 
added (mg/ml) 
Peak area Amt recovered 
(mg) 
% 
recovery 
1 0.05823 0.204 305950.81 0.199 97.54 % 
2 0.05778 0.204 304576.25 0.202 99.01 % 
3 0.05854 0.204 307563.50 0.200 98.03 % 
4 0.05902 0.204 308028.18 0.198 97.05 % 
5 0.05867 0.204 308484.09 0.201 98.52 % 
 
 
Table no: 27 Recovery studies for brand II - Ropin 
S.No Wt of test 
(g) 
Amt of std 
added (mg/ml) 
Peak area Amt recovered 
(mg) 
% 
recovery 
1 0.05498 0.204 305339.98 0.197 96.56 % 
2 0.05567 0.204 308225.74 0.196 96.08 % 
3 0.05523 0.204 308119.36 0.203 99.50 % 
4 0.05492 0.204 306155.43 0.201 98.52 % 
5 0.05565 0.204 308951.75 0.199 97.54 % 
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Chromatogram: 9 
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Chromatogram: 10 
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PARAMETERS USED FOR HPLC METHOD VALIDATION 
Number of Theoretical Plates (N) 
N = 5.54 T / W 
The assessment of performance of efficiency of a column is in terms of the number of 
theoretical plates. 
Where, 
T - Retention time 
W - Width of peak at half height 
 
Tailing Factor  
T = W / 2f 
The assessment of peak shape is in terms of symmetry factor. 
W  -    Width of peak at 5 % height 
 f    -   Distance from the peak maximum to the leading edge of the peak, the distance 
being measured at a point 5 % of the peak height from the baseline (or) width of front 
half of the peak at 5 % height. 
Limit of Detection  
 The detection limit of an individual analytical procedure is the lowest amount 
of an analyte in a sample which can be detected but not necessarily quantitated as an 
exact value. Based on the standard deviation of the response and the slope, the 
detection limit (DL) may be expressed as. 
LOD = 3.3 σ / S 
Where, 
σ    = the standard deviation of the response 
S    = the slope of the calibration curve (of an analyte) 
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Limit of Quantitation 
 The quantitation limit of an analytical procedure is the lowest amount of an 
analyte in a sample which can be quantitatively determined with suitable precision 
and accuracy. Based on the standard deviation of the response and the slope, 
quantitation limit (QL) may be expressed as: 
LOQ = 10 σ / S 
Where, 
σ = the standard deviation of the response 
S = the slope of the calibration curve (of an analyte) [50] 
 
Precision 
 The precision study of this method was done by the data obtained from the 
assay results shown in the table. 
Table no: 28 Data for precision 
 
 
 
 
 
 
S. No. Name of 
tablet 
Std deviation Co-efficient of 
variation  (% RSD) 
SEM 
1 Ropark 1.180 1.1785 0.5276 
2 Ropin 0.9601 0.9441 0.4294 
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Table no:  29 System suitability parameters 
S.No Parameters Observed values Acceptance 
criteria 
1 No. of theoretical 
plates (N) 
2085 Not less than 2000 
2 Tailing factor 0.5 Not more than 2 
3 Linearity range 4 - 16 μg/ml - 
4 Correlation 
coefficient 
0.9998 0.9999 
5 Limit of detection 0.16 μg/ml - 
6 Limit of 
quantitation 
0.48 μg/ml - 
7 % RSD 1.0613 Not more than 2 
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6. RESULTS AND DISCUSSIONS  
 Method - I 
UV Spectrophotometric Determination of Ropinirole Hydrochloride using 0.1 M 
Acetic acid 
 Under the experimental conditions expressed, calibration curve, assay of 
tablets and recovery studies (accuracy) were performed.  
 In this proposed method Beer’s law was obeyed in the concentration range of 
4 - 32 μg/ml.  
 The percentage recovery was found to be 98.36 % for brand I (Ropark) and 
98.16 % for brand II (Ropin). 
 The result of interference studies showed that the excipients present in the 
tablet formulations have no effect in the absorbance of drug. 
 Hence this developed method could be used for routine analysis of ropinirole 
hydrochloride in bulk drug and its formulations. 
Table no: 30 Optical characteristics and statistical data   
λ max 250 nm 
Beer’s law limit (µg/ml) 4 - 32 μg/ml 
Correlation coefficient (r ) 0.9999 
Regression equation* (Y ) 0.0313X+0.0014 
Slope (b) 0.0313 
Intercept (c) 0.0014 
 
* Y = bX + c, where X is the concentration of drug in μg/ml. 
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Method - II 
Extractive Spectrophotometric Estimation of Ropinirole hydrochloride using 0.2 
% Picric acid 
 Under optimum conditions described, the calibration curves were constructed 
for the drug. Assay of tablets and recovery studies (accuracy), stability of colored 
species, effect of concentration of picric acid and effect of volume of reagent were 
performed. 
 This method was obeyed Beer’s law in the concentration range of 2 - 10 
μg/ml. 
 The percentage recovery was found to be 98.55 % for brand I (Ropark) and 
98.18 % for brand II (Ropin). 
 The result of interference studies showed that the excipients present in the 
tablet formulations have no effect in the absorbance of drug. 
 Hence this developed method could be used for the routine analysis of 
ropinirole hydrochloride. 
Table no: 31 Optical characteristics and statistical data   
λ max 410 nm 
Beer’s law limit (µg/ml) 2 - 10μg/ml 
Correlation coefficient (r ) 0.9998 
Regression equation* (Y ) 0.0274X+0.0013 
Slope (b) 0.0274 
Intercept (c) 0.0013 
 
* Y = bX + c, where X is the concentration of drug in μg/ml. 
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Method - III 
RP-HPLC Method for the Estimation of Ropinirole hydrochloride 
 RP-HPLC method was developed as per ICH guidelines. The system 
suitability parameters proved that the proposed method is suitable for the estimation 
of ropinirole hydrochloride. 
 The chromatograms of ropinirole hydrochloride were found to be satisfactory 
on chromosil C18, 5μm, 250 mm x 4.6 mm, using mobile phase composition of buffer 
and acetonitrile in the ratio of 70:30.  The proposed system of stationary phase and 
mobile phase was ideally suitable for this estimation as indicated by good number of 
theoretical plates. The sensitivity of the method was good and also linearity was 
observed over a concentration range of 4 - 16 μg/ml. The accuracy of the method was 
determined by recovery studies and it was found to be 98.03 % for brand I (Ropark) 
and 97.64 % for brand II (Ropin). 
 Hence this developed RP-HPLC method could be used for routine analysis of 
ropinirole hydrochloride. 
Table no: 32 System suitability parameters 
S.No Parameters Observed values Acceptance 
criteria 
1 No. of theoretical 
plates (N) 
2085 Not less than 2000 
2 Tailing factor 0.5 Not more than 2 
3 Linearity range 4 - 16 μg/ml - 
4 Correlation 
coefficient 
0.9998 0.9999 
5 Limit of detection 0.16 μg/ml - 
6 Limit of 
quantitation 
0.48 μg/ml - 
7 % RSD 1.0613 Not more than 2 
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